Insider Trading & Ownership - Gros David-Alexandre C

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Gros David-Alexandre C
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-12-20
Purchase
2021-12-21
4:05 pm
Eledon Pharmaceuticals Inc.ELDNGros David-Alexandre C
Chief Executive Officer
2,000$4.48$8,9609,000
(Direct)
View
2021-08-17
Purchase
2021-08-19
4:05 pm
Eledon Pharmaceuticals Inc.ELDNGros David-Alexandre C
Chief Executive Officer
4,000$6.21$24,8407,000
(Direct)
View
2021-06-09
Purchase
2021-06-10
5:25 pm
Eledon Pharmaceuticals Inc.ELDNGros David-Alexandre C
Chief Executive Officer
3,000$8.01$24,0303,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-05-01
Option Award
2023-05-02
6:49 pm
N/A
2033-05-01
Eledon Pharmaceuticals Inc.ELDNGros David-Alexandre C
Chief Executive Officer
383,299$0383,299
(Direct)
View
2023-02-01
Option Award
2023-02-02
5:56 pm
N/A
2033-02-01
Eledon Pharmaceuticals Inc.ELDNGros David-Alexandre C
Chief Executive Officer
453,600$0453,600
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:38 pm
N/A
2032-02-01
Eledon Pharmaceuticals Inc.ELDNGros David-Alexandre C
Chief Executive Officer
108,000$0108,000
(Direct)
View
2020-09-11
Option Award
2020-09-15
8:12 pm
N/A
2020-09-11
Novus Therapeutics Inc.NVUSGros David-Alexandre C
Chief Executive Officer
18,278$018,278
(Direct)
View